Lannett ships morphine product

PHILADELPHIA—Lannett has started shipping a painkiller product approved by the Food and Drug Administration in June, the company said.



Lannett announced the shipment of morphine sulfate oral solution. Lannett sought FDA approval using a 505(b)(2) new drug application. Sales of morphine sulfate oral solution at average wholesale price were $31.7 million during the 12-month period ending in June, according to Wolters Kluwer.



"This is our first drug approval using a 505(b)(2) application," Lannett president and CEO Arthur Bedrosian said. "We have received orders from drug wholesalers, nursing home providers and distributors."